I'm delighted for the opportunity to teach our University of Toronto medical trainees. Thank you U of T Medical Oncology Residency Training program for this recognition.
Today we worked on the “bell ringer” OSCE prep with our core 3rd year internal medicine residents. Yesr after year I’m convinced these are some of the brightest minds! Love going through those differentials. Passion for education at the grassroots level. @UofT_DoM
Forever grateful to be a part of the Princess Margaret to Cancer Center with groundbreaking research made possible by tremendous support from our community. Thank you Peter Gilgan for your incredible donation to our cause and academic community. #cancercare#earlydetection
Using AI for case presentations and close to real life pictures, helps to bring cases to life. #AI#MedicalEducation. Great audience at Humber River Hospital. Thank you for the invitation. #RCC
Attending the adolescent and young adults (AYA) training program at Sick Kids. This is an excellent program highlighting topics such as nutrition, sexual health, fear of recurrence, reproductive assessment, and supporting children of adult patients. @SickKidsToronto
Today's Fact Friday,
Over 9,000 patients will be diagnosed with kidney cancer in Canada this year - There is no cure.
Let's do our part & MOVE to Beat Cancer and bring hope to finding that cure!
JOIN or DONATE today!
https://t.co/xlKUjdzcTQ
It’s always fun doing a presentation in front of our urology colleagues. @CanUrolAssoc Thank you for inviting me. Princess Margaret Cancer Center Uro-oncology dialogues: “Metastatic kidney cancer: when should we operate?”
Productive session with visiting Dr. Saleh @Ramysaleh86 from McGill university, reviewing approach to systemic therapy for advanced RCC. What’s in the future: Dosing TKI’s wisely in combo with IO frontline, SC IO, RLT’s, moving HIF-2alpha’s forward in trials. Great debates.
Thank you for the invitation! It’s always a pleasure. There were amazing speakers this year including Dr. Chris Booth: common sense oncology. These sessions help me keep up to date as well.
JOIN US FOR THIS EVENT!
Groundbreaking advancements in the treatment of patients with advanced urothelial carcinoma / Tuesday September 10, 2024 / 19:00 - 20:00 ET
REGISTRATION IS FREE >>> https://t.co/PIbm7KHzzu
I had a terrific experience participating in an observership program at 12 de Octubre University Hospital. I particularly enjoyed being educated about access to oncology therapeutics in various parts of the world. #kidneycancer#bladdercancer#prostatecancer#spain
Back to basics! @CanUrolAssoc looking forward to teaching a basic science of oncology course to Canadian PGY 1-2 urology residents about chemo, VEGF inhibitors, radio-pharmaceuticals, and immune check point inhibition commonly used in treatment of GU cancers.
2 in 5 Canadians are expected to be diagnosed with cancer in their lifetime. Approximately 1 in 4 Canadians is expected to die of the disease. Often the question is “Why me?”. The answer is often “It’s nothing you did. It’s simply chance.” #cancer
At #JSMO with 3 controversies from ASCOGU 1) The -ve OS adjuvant pembro data in UC questions this approach more broadly. Censoring ++ on KM curve though. 2) More data needed to prove atezo is active with cabo in CRPC. 3)Ipi/nivo looks as good as anything else in good risk M1 RCC
Genetics and genomics, two words we hear together more and more. They seem to be used interchangeably but are there any differences? Dr. Raymond Kim, medical geneticist, accepted our invitation for a more in-depth look on the subject https://t.co/TnwaJtpwB3 #kidneycancer
🔔 Our #GUCancers Symposium Roundtable Discussions are now available for on-demand viewing. Watch as @fallah_rad, @sebastienhotte & @DiMariaJiang analyze some of the most notable trials presented around bladder, kidney & prostate cancer: https://t.co/MqUukpSV2T
#MedOnc#OncEd